<DOC>
	<DOCNO>NCT01101425</DOCNO>
	<brief_summary>Rationale : Gathering medical information tumor sample patient male breast cancer may help doctor learn disease . Purpose retrospective part : perform large international retrospective analysis clinical biological data male BC patient treat participate center 1990 2010 . Purpose prospective part : create registry men breast cancer period 30 month ( start early 2014 ) .</brief_summary>
	<brief_title>Male Breast Cancer : Understanding Biology Improved Patient Care</brief_title>
	<detailed_description>Objectives retrospective part ( closed patient registration September 2013 ) : - To perform large international joint retrospective analysis clinical biological data male breast cancer ( BC ) patient treat 1990 2010 . - To create database patient characteristic , disease feature , treatment receive , clinical outcome large series men diagnose BC 1990 2010 center Europe USA . - To perform central pathological review correspond large series male BC tumor determine biologic characteristic identify relevant prognostic predictive marker . Objectives prospective part ( open early 2014 ) : - To run prospective registry male BC patient ( include newly diagnose ) irrespective stage treatment , participate institution period 30 month ; collection FFPE , fresh frozen blood sample optional highly encourage . - Quality Life sub-study The two part study provide important information regard male BC biology clinical evolution . The collected follow-up information provide overview current practice early advance disease also offer precious information disease evolution rare patient ' population .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms , Male</mesh_term>
	<criteria>Retrospective part ( closed patient registration ) : Men histologically proven invasive breast carcinoma diagnose since 1990 2010 . A FFPE tissue sample primary tumor ( e.g . biopsy surgery ) mandatory Prospective part : All men , histologically proven invasive breast cancer , newly present center irrespective stage disease , initial diagnosis date treatment receive . patient register retrospective protective part study patient newly present center 3 month prior center activation still eligible long previously include retrospective part study Before patient registration , write informed consent must obtain accord ICH/GCP , national/local regulation . Collection leftover FFPE frozen tumor sample well blood optional . Both part : Concomitant DCIS LCIS allow invasive cancer present . Patients 18 year time diagnosis . The study accept stage disease ( e.g . early BC , locally advanced metastatic disease ) independent treatment receive . Patients past concurrent malignancy eligible .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>male</keyword>
	<keyword>breast cancer</keyword>
</DOC>